Mah Lee Mary Ng

Title: Mah Lee Mary Ng: Innovator in Dengue Virus Research

Introduction

Mah Lee Mary Ng is a prominent inventor based in Singapore, known for her significant contributions to the field of medical research, particularly in the area of dengue virus treatment. With a total of two patents to her name, she has made strides in developing innovative solutions to combat this infectious disease.

Latest Patents

Ng's latest patents focus on human monoclonal antibodies with specificity for dengue virus serotype 1 E protein. These patents detail compositions and methods for the treatment or prevention of dengue virus infection in vertebrate subjects. Specifically, they disclose human neutralizing monoclonal antibodies isolated from EBV immortalized B cells derived from patients who have recovered from dengue infection. The methods outlined in these patents provide a framework for administering such antibodies in amounts effective to reduce, eliminate, or prevent relapse from infection.

Career Highlights

Throughout her career, Mah Lee Mary Ng has worked with esteemed institutions such as the National University of Singapore and DSO National Laboratories. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Paul Macary and Ee Ping Evelyn Teoh, who have played significant roles in her research endeavors.

Conclusion

Mah Lee Mary Ng's innovative work in the field of dengue virus research exemplifies her commitment to advancing medical science. Her patents and collaborations highlight her contributions to developing effective treatments for infectious diseases.